These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16023702)

  • 1. Activated protein C resistance: the influence of ABO-blood group, gender and age.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L
    Thromb Res; 2006; 117(6):665-70. PubMed ID: 16023702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ; Mirochnik O; McDonald D
    Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory identification of familial thrombophilia: do the pitfalls exceed the benefits? A reassessment of ABO-blood group, gender, age, and other laboratory parameters on the potential influence on a diagnosis of protein C, protein S, and antithrombin deficiency and the potential high risk of a false positive diagnosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L
    Lab Hematol; 2005; 11(3):174-84. PubMed ID: 16174603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an activated partial thromboplastin time with a Russell viper venom time test in screening for factor V(Leiden) (FVR506Q).
    Sweeney JD; Blair AJ; King TC
    Am J Clin Pathol; 1997 Jul; 108(1):74-7. PubMed ID: 9208981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
    Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
    Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 9-year retrospective assessment of laboratory testing for activated protein C resistance: evolution of a novel approach to thrombophilia investigations.
    Favaloro EJ; Orsag I; Bukuya M; McDonald D
    Pathology; 2002 Aug; 34(4):348-55. PubMed ID: 12190294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Russell viper venom-based and activated partial thromboplastin time-based screening assays for resistance to activated protein C.
    Herskovits AZ; Lemire SJ; Longtine J; Dorfman DM
    Am J Clin Pathol; 2008 Nov; 130(5):796-804. PubMed ID: 18854273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired APC resistance and oral contraceptives: differences between two functional tests.
    Curvers J; Thomassen MC; Nicolaes GA; Van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Br J Haematol; 1999 Apr; 105(1):88-94. PubMed ID: 10233368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay.
    Curvers J; Christella M; Thomassen LG; de Ronde H; Bertina RM; Rosendaal FR; Tans G; Rosing J
    Thromb Haemost; 2002 Mar; 87(3):483-92. PubMed ID: 11924538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The routine coagulation tests along with activated protein C resistance (APC-R) in population of women applying for oral contraceptives].
    Kostecka I; Dabrowska M; Osada J; Suchowierska M; Wołczyński S
    Przegl Lek; 2001; 58(12):1038-40. PubMed ID: 12041017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of freezing plasma at -20°C for 2 weeks on prothrombin time, activated partial thromboplastin time, dilute Russell viper venom time, activated protein C resistance, and D-dimer levels.
    Foshat M; Bates S; Russo W; Huerta A; Albright K; Giddings K; Indrikovs A; Qian YW
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):41-7. PubMed ID: 24842886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay.
    Gardiner C; Cohen H; Jenkins A; Machin SJ; Mackie IJ
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):477-83. PubMed ID: 16905952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxaemia induces resistance to activated protein C in healthy humans.
    de Pont AC; Bakhtiari K; Hutten BA; de Jonge E; Vlasuk GP; Rote WE; Levi M; Büller HR; Meijers JC
    Br J Haematol; 2006 Jul; 134(2):213-9. PubMed ID: 16846480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
    De Bel AV; Van der Cruyssen GA; Devreese KM
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
    Kafkas S; Kalkan U; Bolaman Z; Sanci M; Yüksel H; Odabaşi AR
    Gynecol Obstet Invest; 2007; 64(2):89-94. PubMed ID: 17314487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC resistance during the normal menstrual cycle.
    van Rooijen M; Silveira A; Thomassen S; Odeberg J; Hamsten A; Rosing J; Bremme K
    Thromb Haemost; 2007 Dec; 98(6):1246-51. PubMed ID: 18064321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.